$27.49
0.823.07%
At Close: -
$27.49
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
BridgeBio Pharma
BBIONASDAQ
BridgeBio Pharma (NASDAQ:BBIO) Stock, Earnings Estimates, EPS, And Revenue
BridgeBio Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 5
EPS Estimate
$-1.040
Quarterly Revenue Estimate
$3.6M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$218.6M
Analyze the earnings history of BridgeBio Pharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma | -$0.98 | -$1.04 | — | — | $1.64M | $3.57M | — | — | 08/05/2024 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.92 | -$0.89 | -$0.20 | 77.53% | $1.83M | $14.03M | $211.12M | 1404.78% | 05/02/2024 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.92 | -$0.91 | -$0.96 | -5.49% | $1.87M | $6.23M | $1.75M | -71.99% | 02/22/2024 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.93 | -$0.81 | -$1.08 | -33.33% | $338.00K | $4.26M | $4.09M | -3.97% | 11/02/2023 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.83 | -$0.83 | -$0.98 | -18.07% | $73.75M | $2.99M | $1.64M | -45.12% | 08/03/2023 | Get Alert |
| BBIO | BridgeBio Pharma | -$1.35 | -$0.83 | -$0.92 | -10.84% | $1.69M | $3.37M | $1.83M | -45.82% | 05/04/2023 | Get Alert |
| BBIO | BridgeBio Pharma | -$1.01 | -$0.85 | -$0.92 | -8.24% | $12.89M | $4.52M | $1.87M | -58.63% | 02/23/2023 | Get Alert |
| BBIO | BridgeBio Pharma | -$1.06 | -$0.99 | -$0.93 | 6.06% | $2.34M | $7.90M | $338.00K | -95.72% | 11/03/2022 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.66 | -$0.63 | -$0.81 | -28.57% | $54.02M | $16.07M | $73.75M | 358.90% | 08/04/2022 | Get Alert |
| BBIO | BridgeBio Pharma | -$1.18 | -$1.11 | -$1.19 | -7.21% | $462.00K | $4.69M | $1.69M | -63.88% | 05/05/2022 | Get Alert |
| BBIO | BridgeBio Pharma | -$1.01 | -$0.87 | -$1.01 | -16.09% | $122.00K | $21.58M | $12.89M | -40.29% | 02/24/2022 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.98 | -$0.90 | -$1.06 | -17.78% | $8.13M | $17.36M | $2.34M | -86.50% | 11/04/2021 | Get Alert |
| BBIO | BridgeBio Pharma | -$1.03 | -$0.96 | -$0.66 | 31.25% | $0.00 | $29.12M | $54.02M | 85.52% | 08/05/2021 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.78 | -$0.80 | -$1.18 | -47.50% | $0.00 | $32.10M | $462.00K | -98.56% | 05/06/2021 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.62 | — | -$1.01 | — | $13.82M | — | $122.00K | — | 02/25/2021 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.51 | — | -$0.98 | — | $26.74M | — | $8.13M | — | 11/05/2020 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.71 | — | -$1.03 | — | $0.00 | — | $0.00 | — | 08/11/2020 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.66 | — | -$0.78 | — | — | — | $0.00 | — | 05/13/2020 | Get Alert |
| BBIO | BridgeBio Pharma | — | -$0.70 | -$0.62 | 11.43% | — | — | $13.82M | — | 03/02/2020 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.52 | — | -$0.51 | — | — | — | $26.74M | — | 11/07/2019 | Get Alert |
| BBIO | BridgeBio Pharma | — | — | -$3.46 | — | — | — | $0.00 | — | 08/14/2019 | Get Alert |
BridgeBio Pharma (BBIO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-02 | $-0.20 | $-0.89 | 77.5 % |
| Dec 2023 | 2024-02-22 | $-0.96 | $-0.91 | -5.49 % |
| Sep 2023 | 2023-11-02 | $-1.08 | $-0.81 | -33.3 % |
| Jun 2023 | 2023-08-03 | $-0.98 | $-0.83 | -18.1 % |
BridgeBio Pharma (BBIO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-02 | $211.12M | $14.03M | 1404.8 % |
| Dec 2023 | 2024-02-22 | $1.75M | $6.23M | -72.0 % |
| Sep 2023 | 2023-11-02 | $4.09M | $4.26M | -3.97 % |
| Jun 2023 | 2023-08-03 | $1.64M | $2.99M | -45.1 % |
FAQ
When is BridgeBio Pharma (NASDAQ:BBIO) reporting earnings?
BridgeBio Pharma (BBIO) is scheduled to report earnings on August 5, 2024. The last reported earnings were for reported on May 2, 2024 for Q1.
What were the latest earnings per share (EPS) for BridgeBio Pharma (NASDAQ:BBIO)?
The Actual EPS was $-0.20, which beat the estimate of $-0.89.
What were BridgeBio Pharma’s (NASDAQ:BBIO) revenues?
The Actual Revenue was $211.1M, which beat the estimate of $14M.
Browse earnings estimates, EPS, and revenue on all stocks.